Oxurion NV (FRA:TG40) Long-Term Debt : €0.00 Mil (As of Jun. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Oxurion NV Long-Term Debt?

Oxurion NV's Long-Term Debt for the quarter that ended in Jun. 2024 was €0.00 Mil.

Oxurion NV's quarterly Long-Term Debt declined from Jun. 2023 (€0.77 Mil) to Dec. 2023 (€0.00 Mil) but then stayed the same from Dec. 2023 (€0.00 Mil) to Jun. 2024 (€0.00 Mil).

Oxurion NV's annual Long-Term Debt declined from Dec. 2021 (€8.43 Mil) to Dec. 2022 (€3.24 Mil) and declined from Dec. 2022 (€3.24 Mil) to Dec. 2023 (€0.00 Mil).

Oxurion NV Long-Term Debt Historical Data

The historical data trend for Oxurion NV's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxurion NV Long-Term Debt Chart

Oxurion NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

8.43

3.24

Oxurion NV Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Long-Term Debt	Get a 7-Day Free Trial															4.47	3.24	0.77	-	-

Oxurion NV (FRA:TG40) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Oxurion NV Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Oxurion NV's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxurion NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxurion NV (FRA:TG40) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

OXUR:Belgium

Address

Gaston Geenslaan 1, Leuven, BEL, B-3001

Website

https://www.oxurion.com

Oxurion NV is a clinical-stage biopharmaceutical company developing next-generation standard-of-care ophthalmic therapies, which are designed to improve and preserve vision in patients with retinal disorders including Geographic Atrophy (GA). The Group's research and development facilities are located in Belgium. The Company is engaged in the development of drugs to treat blindness diseases.

Oxurion NV Headlines

No Headlines